An Open-Label Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn’s Disease (Holiday)
Brief Description Of Study
You are being asked to take part in this research study because you have Crohn’s disease and the medical treatments you have tried have not brought you to full remission (clinically and physically symptom free).
Detailed Study Description
If you agree to take part, your participation will last for 6-7 months and will involve 5 study visits each of approximately 60 minutes in length and 3 telephone calls each of approximately 30 minutes in length. You might be eligible to participate in this trial if: 1. You have Crohn’s Disease 2. You are between the ages of 18-64 3. You have tried multiple therapies with NO relief 4. You failed 8 weeks of: • Azathioprine • 6-mercaptopureine • Methotrexate • Adalimumab • Certolizumab • Golimumab • Infliximab • Natalizumab OR • Vedolizumab